Medullary Thyroid Cancer

    loading  Checking for direct PDF access through Ovid


Overview and case study of a rare cancerBACKGROUND:Medullary thyroid cancer (MTC) is a rare cancer that has historically been managed by endocrinologists. In 2011, the first of several multi-targeted tyrosine kinase inhibitors was approved as treatment for MTC. These drugs have changed the management of MTC to teams that include oncologists and oncology nurses.OBJECTIVES:This article illustrates MTC diagnostics, surveillance, management of adverse drug reactions, and disease progression through a case study.METHODS:An overview of MTC is offered, followed by an in-depth case study that examines MTC from the patient's perspective.FINDINGS:Oncology nurses can influence patient outcomes through the provision of patient education, support, and management of disease and treatment complications.

    loading  Loading Related Articles